Endometriosis is a common and serious illness affecting women in their reproductive years. Despite the ongoing interest and intensive research of this crippling disease, the cause remains unknown since its first description over 150 years ago. The origins and genesis of endometriosis, despite numerous hypotheses, are still unclear. One of the possible causes of the development of endometriosis might be the immune system, despite the fact that endometriosis is generally considered to be a steroid-sensitive disease. Numerous aspects of the immune system has been found changed, from the different number of activated macrophages to different subtypes of lymphocytes and their activities, suggesting involvement of immunity. On the other hand, it is possible that immunological changes around the endometriotic lesion are only secondary to the establishment of endometriosis. In this review, we will summarize the current knowledge of immunological reactions in endometriosis.

Department of Histology and Embryology Faculty of Medicine Charles University Karlovarska 48 Plzen 301 00 Czech Republic ; 2 Department of Obstetrics and Gynecology University Hospital Faculty of Medicine Charles University Alej Svobody 80 Plzen 301 66 Czech Republic ; 3 Biomedical Centre Faculty of Medicine in Plzen Charles University Plzen Czech Republic ; 4 Department of Pathology University of Louisville 511 S Floyd Louisville KY 40202 USA

Zobrazit více v PubMed

Von Rokitansky C. Uber Uterusdrusen-Neuerbildung in Uterus and Ovarilsarcomen, Z Gesselschaft Aerzte Wien 1860;37:577-93.

Wood DH, Yochmowitz MG, Salmon YL, et al. Proton irradiation and endometriosis. Aviat Space Environ Med 1983;54:718-24. PubMed

Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33-6. PubMed

Kanzaki H, Wang HS, Kariya M, et al. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992;167:257-61. PubMed

Tanaka E, Sendo F, Kawagoe S, et al. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992;34:27-30. PubMed

Viganò P, Somigliana E, Di Blasio AM, et al. Suppression of natural killer cell function and production of soluble ICAM-1: endometrial stroma versus melanoma. Am J Reprod Immunol 2001;46:342-8. PubMed

Oosterlynck DJ, Meuleman C, Waer M, et al. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993;82:206-12. PubMed

Semino C, Semino A, Pietra G, et al. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertil Steril 1995;64:909-16. PubMed

Osuga Y, Koga K, Hirota Y, et al. Lymphocytes in endometriosis. Am J Reprod Immunol 2011;65:1-10. PubMed

Hornung D, Fujii E, Lim KH, et al. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001;75:814-7. PubMed

Wu MY, Yang JH, Chao KH, et al. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000;74:1187-91. PubMed

Chrobak A, Gmyrek GB, Sozański R, et al. The influence of extracellular matrix proteins on T-cell proliferation and apoptosis in women with endometriosis or uterine leiomyoma. Am J Reprod Immunol 2004;51:123-9. PubMed

Melioli G, Semino C, Semino A, et al. Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993;30:218-27. PubMed

Ho HN, Wu MY, Chao KH, et al. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 1997;12:2528-33. PubMed

Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011;88:149-55. PubMed

Budiu RA, Diaconu I, Chrissluis R, et al. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Dis Model Mech 2009;2:593-603. PubMed

Vlad AM, Diaconu I, Gantt KR. MUC1 in endometriosis and ovarian cancer. Immunol Res 2006;36:229-36. PubMed

Wu MH, Shoji Y, Wu MC, et al. Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 2005;167:1061-9. PubMed PMC

de Villiers WJ, Fraser IP, Gordon S. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol Lett 1994;43:73-9. PubMed

Viganò P, Gaffuri B, Somigliana E, et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-6. PubMed

Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981;141:377-83. PubMed

Maeda N, Izumiya C, Oguri H, et al. Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertil Steril 2002;77:679-83. PubMed

Capobianco A, Monno A, Cottone L, et al. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol 2011;179:2651-9. PubMed PMC

Králíčková M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol 2014;5:800-5. PubMed PMC

Pasoto SG, Abrao MS, Viana VS, et al. Endometriosis and systemic lupus erythematosus: a comparative evaluation of clinical manifestations and serological autoimmune phenomena. Am J Reprod Immunol 2005;53:85-93. PubMed

Matorras R, Ocerin I, Unamuno M, et al. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome. Lupus 2007;16:736-40. PubMed

Taylor PV, Maloney MD, Campbell JM, et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991;98:680-4. PubMed

Garza D, Mathur S, Dowd MM, et al. Antigenic differences between the endometrium of women with and without endometriosis. J Reprod Med 1991;36:177-82. PubMed

Yeaman GR, Collins JE, Lang GA. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 2002;955:174-82; discussion 199-200, 396-406. PubMed

Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig 2006;13:467-76. PubMed

Tanaka T, Umesaki N, Mizuno K, et al. Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study. Clin Exp Obstet Gynecol 2000;27:133-7. PubMed

Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002;78:665-78. PubMed

Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994;31:151-62. PubMed

Olovsson M. Immunological aspects of endometriosis: an update. Am J Reprod Immunol 2011;66 Suppl 1:101-4. PubMed

Suryawanshi S, Huang X, Elishaev E, et al. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2014;20:6163-74. PubMed PMC

Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med 1998;43:252-62. PubMed

Iwabe T, Harada T, Tsudo T, et al. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998;69:924-30. PubMed

Bulun SE, Cheng YH, Pavone ME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43. PubMed PMC

Gilmore SM, Aksel S, Hoff C, et al. In vitro lymphocyte activity in women with endometriosis--an altered immune response? Fertil Steril 1992;58:1148-52. PubMed

Antsiferova YS, Sotnikova NY, Posiseeva LV, et al. Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 2005;84:1705-11. PubMed

Gmyrek GB, Sieradzka U, Goluda M, et al. Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest 2008;37:43-61. PubMed

Ali AF, Fateen B, Ezzet A, et al. Laparoscopic intraperitoneal injection of human interferon-α2b in the treatment of pelvic endometriosis: a new modality. Obstet Gynecol 2000;95:47S-8S.

D'Antonio M, Martelli F, Peano S, et al. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. J Reprod Immunol 2000;48:81-98. PubMed

Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002;17:426-31. PubMed

Kao AP, Wang KH, Long CY, et al. Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma. Fertil Steril 2011;96:678-84. PubMed

Herington JL, Bruner-Tran KL, Lucas JA, et al. Immune interactions in endometriosis. Expert Rev Clin Immunol 2011;7:611-26. PubMed PMC

Endometriosis and gynaecological cancers: molecular insights behind a complex machinery

Effect of psychosocial trauma and stress on sexual dysfunction in women with endometriosis